SA Health Products Regulatory Authority (SAHPRA) announced that the regulatory approval for Covid-19 vaccines will be fast tracked. The first applications are expected within a fortnight and the first vaccines from the Covax global vaccine distribution scheme should start in the second quarter of next year. Yuven Gounden, the authority’s spokesperson, said SAHPRA a “rolling review approach” will be followed where vaccine candidate evaluation is done as data becomes available. The regulator will rely on guidance from the World Health Organisation (WHO) and work done by international counterparts, such as European and US pharmaceutical regulators, to avoid repeating work already done that could delay approvals.

Other news